newsfilter
← Latest News
ACCESS Newswire·

AIML Subsidiary NeuralCloud Signs Agreement With MyCor360+ to Integrate MaxYield(TM) into Next-Generation Cardiac Monitoring Device

AIMLF
  • AI/ML Innovations Inc. (AIML) announced that its subsidiary, NeuralCloud Solutions Inc., entered a non-binding agreement with MyCor360+ to explore integrating NeuralCloud's MaxYield™ ECG signal-processing technology into a new cardiac monitoring device.
  • The collaboration aims to combine MyCor360+'s developing ECG recording hardware with NeuralCloud's AI-powered software to enhance signal clarity, reduce noise, & improve clinical ECG analysis workflows.
  • MyCor360+ will manage device development & commercialization through a manufacturing partner, while NeuralCloud provides the MaxYield™ engine which identifies P waves, QRS complexes, & T waves to generate structured, machine-readable data.
  • The proposed device is a disposable, single-use solution capable of 14-day monitoring with cellular-enabled automated data transmission & a clinician portal for integration with electronic medical records.
  • NeuralCloud's President Esmat Naikyar stated the partnership addresses challenges in separating cardiac signals from noise while preserving detailed waveform information.
  • AIML CEO Paul Duffy noted the agreement supports a strategy to establish MaxYield™ as a core signal-processing layer for next-generation medical devices & OEM partners.
  • The current agreement is non-binding & any definitive commercial arrangement is subject to further technical development, regulatory requirements, & successful integration.
  • Neither MaxYield™ nor the MyCor360+ device has received FDA clearance for the proposed application, & commercial deployment requires applicable regulatory approvals.
Company
AI/ML Innovations Inc.
Keywords
Publishing & Media, Company Update